pharma news today glp-1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Drug ad enforcement ramps up–again

The September 2024 LIFT-AD trial termination after meeting enrollment demonstrates that this approach, despite decades of development, does not slow Alzheimer's cognitive decline in humans

rather, it is a stack of two synergistic Peptides that mimic the body's natural release mechanisms, providing a stable, sustained, and natural surge of Growth Hormone

In men, increasing testosterone and reducing estrogen levels can increase lean muscle mass and bone density and reduce fat mass , which is crucial for maintaining a healthy body composition

Studies have shown complex interactions between GHK-Cu and MMP-2, with effects that vary by concentration and cellular context

El-Far MA, Bakr MA, Farahat SE, Abd El-Fattah EA